Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia
Open Access
- 1 March 2001
- Vol. 48 (3) , 347-355
- https://doi.org/10.1136/gut.48.3.347
Abstract
BACKGROUND/AIMS We aimed to evaluate the role of fat and cholecystokinin (CCK) in the pathophysiology of functional dyspepsia (FD) by investigating symptoms and plasma CCK levels following increasing doses of duodenal lipid during gastric distension, and the effect of CCK-A receptor blockade. SUBJECTS/METHODS In study A, six FD patients were studied on three occasions during duodenal infusion of saline or lipid (1.1 (L-1) or 2 kcal/min (L-2)) and proximal gastric distensions. Six healthy subjects were also studied as controls during L-2 only. In study B, the effect of the CCK-A antagonist dexloxiglumide (5 mg/kg/h) on L-2 induced symptoms was studied in 12 FD patients. Changes in gastric volume at minimal distending pressure and plasma CCK (study A) were assessed, gastric distensions were performed using a barostat, and dyspeptic symptoms were monitored. RESULTS Lipid increased gastric volume compared with saline (ΔV (ml): saline 15 (20), L-1 122 (42), L-2 114 (28)) in patients and even more so in controls (221 (37); pCONCLUSION CCK-A receptors are involved in the generation of dyspeptic symptoms by duodenal lipid during gastric distension.Keywords
This publication has 32 references indexed in Scilit:
- Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disordersExpert Opinion on Investigational Drugs, 1997
- Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipidGastroenterology, 1996
- Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsiaEuropean Journal of Gastroenterology & Hepatology, 1995
- Loxiglumide, a CCK‐A Antagonist, in Irritable Bowel SyndromeAnnals of the New York Academy of Sciences, 1994
- Clinical Efficacy and Prokinetic Effect of the CCK-A Antagonist Loxiglumide in Nonulcer DyspepsiaAnnals of the New York Academy of Sciences, 1994
- Cholecystokinin Hyperresponsiveness in Dysmotility‐Type Nonulcer DyspepsiaAnnals of the New York Academy of Sciences, 1994
- Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsiaDigestive Diseases and Sciences, 1991
- Visceral perception in health and functional dyspepsiaDigestive Diseases and Sciences, 1991
- Cholecystokinin Release by Gastric Distension – An Atropine-Sensitive MechanismDigestion, 1990
- INFLUENCE OF AGE ON INTRAVENOUS GLUCOSE TOLERANCE AND SERUM IMMUNOREACTIVE INSULINThe Lancet, 1966